25 XP   0   0   10

Dr. Reddy's Laboratories Limited
Buy, Hold or Sell?

Let's analyse Dr. Reddy's Laboratories Limited together

PenkeI guess you are interested in Dr. Reddy's Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dr. Reddy's Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dr. Reddy's Laboratories Limited

I send you an email if I find something interesting about Dr. Reddy's Laboratories Limited.

Quick analysis of Dr. Reddy's Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Dr. Reddy's Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.84
When do you have the money?
1 year
How often do you get paid?
65.0%

What is your share worth?

Current worth
INR1,606.05
Expected worth in 1 year
INR1,889.32
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
INR353.04
Return On Investment
5.9%

For what price can you sell your share?

Current Price per Share
INR5,952.10
Expected price per share
INR5,521 - INR6,506
How sure are you?
50%

1. Valuation of Dr. Reddy's Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR5,952.10

Intrinsic Value Per Share

INR379.59 - INR1,156.72

Total Value Per Share

INR1,985.64 - INR2,762.78

2. Growth of Dr. Reddy's Laboratories Limited (5 min.)




Is Dr. Reddy's Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$3.2b$2.4b$515.3m17.2%

How much money is Dr. Reddy's Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$156.6m$148.5m$8.1m5.2%
Net Profit Margin19.2%21.4%--

How much money comes from the company's main activities?

3. Financial Health of Dr. Reddy's Laboratories Limited (5 min.)




What can you expect buying and holding a share of Dr. Reddy's Laboratories Limited? (5 min.)

Welcome investor! Dr. Reddy's Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Dr. Reddy's Laboratories Limited.

What can you expect buying and holding a share of Dr. Reddy's Laboratories Limited?

First you should know what it really means to hold a share of Dr. Reddy's Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Dr. Reddy's Laboratories Limited is INR5,952. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dr. Reddy's Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dr. Reddy's Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR1,606.05. Based on the TTM, the Book Value Change Per Share is INR70.82 per quarter. Based on the YOY, the Book Value Change Per Share is INR45.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR17.44 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dr. Reddy's Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.990.0%0.940.0%0.650.0%0.570.0%0.440.0%
Usd Book Value Change Per Share1.050.0%0.850.0%0.550.0%0.470.0%0.330.0%
Usd Dividend Per Share0.000.0%0.210.0%0.250.0%0.230.0%0.190.0%
Usd Total Gains Per Share1.050.0%1.060.0%0.800.0%0.700.0%0.520.0%
Usd Price Per Share69.65-63.57-51.67-51.90-43.37-
Price to Earnings Ratio17.55-17.17-62.48-82.79-64.68-
Price-to-Total Gains Ratio66.05-61.21-78.04-67.70--1,853.66-
Price to Book Ratio3.61-3.53-3.47-3.81-4.01-
Price-to-Total Gains Ratio66.05-61.21-78.04-67.70--1,853.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share71.4252
Number of shares14
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.210.23
Usd Book Value Change Per Share0.850.47
Usd Total Gains Per Share1.060.70
Gains per Quarter (14 shares)14.839.86
Gains per Year (14 shares)59.3139.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1124849132729
22395108265368
3351431673980107
44719022651106146
55923828564133185
67028634477159224
78233340390186263
894381462103213302
9106428521116239341
10117476580128266380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%39.01.00.097.5%85.06.00.093.4%
Book Value Change Per Share4.00.00.0100.0%11.00.01.091.7%18.01.01.090.0%34.05.01.085.0%78.012.01.085.7%
Dividend per Share2.00.02.050.0%9.00.03.075.0%15.00.05.075.0%26.00.014.065.0%44.00.047.048.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%37.03.00.092.5%82.09.00.090.1%

Fundamentals of Dr. Reddy's Laboratories Limited

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-04-17 07:24:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dr. Reddy's Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dr. Reddy's Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 19.1% means that ₹0.19 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 19.1%. The company is making a huge profit. +2
  • The TTM is 19.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.1%TTM19.2%-0.1%
TTM19.2%YOY21.4%-2.3%
TTM19.2%5Y14.8%+4.4%
5Y14.8%10Y13.0%+1.8%
1.1.2. Return on Assets

Shows how efficient Dr. Reddy's Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.7% Return on Assets means that Dr. Reddy's Laboratories Limited generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 3.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.8%-0.1%
TTM3.8%YOY4.2%-0.4%
TTM3.8%5Y2.8%+0.9%
5Y2.8%10Y2.4%+0.4%
1.1.3. Return on Equity

Shows how efficient Dr. Reddy's Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.1% Return on Equity means Dr. Reddy's Laboratories Limited generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 5.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.2%-0.1%
TTM5.2%YOY6.0%-0.8%
TTM5.2%5Y4.2%+1.0%
5Y4.2%10Y3.9%+0.3%

1.2. Operating Efficiency of Dr. Reddy's Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dr. Reddy's Laboratories Limited is operating .

  • Measures how much profit Dr. Reddy's Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 24.3% means the company generated ₹0.24  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 24.3%. The company is operating efficient. +1
  • The TTM is 26.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ24.3%TTM26.6%-2.3%
TTM26.6%YOY24.2%+2.4%
TTM26.6%5Y18.9%+7.7%
5Y18.9%10Y16.9%+2.0%
1.2.2. Operating Ratio

Measures how efficient Dr. Reddy's Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.77 means that the operating costs are ₹0.77 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.766. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.731. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.766TTM0.731+0.034
TTM0.731YOY0.758-0.026
TTM0.7315Y0.798-0.066
5Y0.79810Y0.830-0.032

1.3. Liquidity of Dr. Reddy's Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.55 means the company has ₹2.55 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 2.548. The company is able to pay all its short-term debts. +1
  • The TTM is 2.530. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.548TTM2.530+0.018
TTM2.530YOY2.114+0.416
TTM2.5305Y2.028+0.502
5Y2.02810Y1.839+0.188
1.3.2. Quick Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.49 means the company can pay off ₹2.49 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 2.494. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.429. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.494TTM2.429+0.065
TTM2.429YOY1.666+0.763
TTM2.4295Y1.642+0.787
5Y1.64210Y1.524+0.118

1.4. Solvency of Dr. Reddy's Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dr. Reddy's Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dr. Reddy's Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Dr. Reddy's Laboratories Limited assets are financed with 28.2% credit (debt) and the remaining percentage (100% - 28.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.282. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.275. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.275+0.007
TTM0.275YOY0.306-0.032
TTM0.2755Y0.323-0.048
5Y0.32310Y0.377-0.054
1.4.2. Debt to Equity Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 39.2% means that company has ₹0.39 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.392. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.379. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.392TTM0.379+0.013
TTM0.379YOY0.442-0.063
TTM0.3795Y0.480-0.101
5Y0.48010Y0.621-0.141

2. Market Valuation of Dr. Reddy's Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dr. Reddy's Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Dr. Reddy's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 17.55 means the investor is paying ₹17.55 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dr. Reddy's Laboratories Limited:

  • The EOD is 17.997. Based on the earnings, the company is fair priced.
  • The MRQ is 17.550. Based on the earnings, the company is fair priced.
  • The TTM is 17.170. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.997MRQ17.550+0.448
MRQ17.550TTM17.170+0.380
TTM17.170YOY62.481-45.311
TTM17.1705Y82.786-65.616
5Y82.78610Y64.681+18.104
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dr. Reddy's Laboratories Limited:

  • The EOD is -813.659. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -793.414. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -249.401. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-813.659MRQ-793.414-20.245
MRQ-793.414TTM-249.401-544.013
TTM-249.401YOY-34.556-214.845
TTM-249.4015Y-61.765-187.636
5Y-61.76510Y-24.390-37.375
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dr. Reddy's Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.61 means the investor is paying ₹3.61 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dr. Reddy's Laboratories Limited:

  • The EOD is 3.706. Based on the equity, the company is fair priced.
  • The MRQ is 3.614. Based on the equity, the company is fair priced.
  • The TTM is 3.528. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.706MRQ3.614+0.092
MRQ3.614TTM3.528+0.085
TTM3.528YOY3.473+0.055
TTM3.5285Y3.812-0.284
5Y3.81210Y4.009-0.196
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dr. Reddy's Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--87.87770.816+24%45.425+93%39.555+122%27.672+218%
Book Value Per Share--1606.0511498.835+7%1241.992+29%1138.322+41%920.455+74%
Current Ratio--2.5482.530+1%2.114+20%2.028+26%1.839+39%
Debt To Asset Ratio--0.2820.275+2%0.306-8%0.323-13%0.377-25%
Debt To Equity Ratio--0.3920.379+3%0.442-11%0.480-18%0.621-37%
Dividend Per Share---17.444-100%21.174-100%19.110-100%15.979-100%
Eps--82.68078.391+5%54.524+52%47.910+73%36.276+128%
Free Cash Flow Per Share---1.82943.052-104%33.093-106%32.112-106%22.721-108%
Free Cash Flow To Equity Per Share--29.84331.750-6%-16.995+157%8.249+262%3.603+728%
Gross Profit Margin--1.0000.595+68%1.0000%0.919+9%0.960+4%
Intrinsic Value_10Y_max--1156.725--------
Intrinsic Value_10Y_min--379.588--------
Intrinsic Value_1Y_max--124.378--------
Intrinsic Value_1Y_min--82.436--------
Intrinsic Value_3Y_max--367.253--------
Intrinsic Value_3Y_min--210.699--------
Intrinsic Value_5Y_max--602.352--------
Intrinsic Value_5Y_min--297.443--------
Market Cap991155596200.000+2%967965118080.000882723016764.750+10%716985449300.000+35%720299297577.950+34%605328481357.568+60%
Net Profit Margin--0.1910.1920%0.214-11%0.148+29%0.130+47%
Operating Margin--0.2430.266-9%0.242+0%0.189+29%0.169+44%
Operating Ratio--0.7660.731+5%0.758+1%0.798-4%0.830-8%
Pb Ratio3.706+2%3.6143.528+2%3.473+4%3.812-5%4.009-10%
Pe Ratio17.997+2%17.55017.170+2%62.481-72%82.786-79%64.681-73%
Price Per Share5952.100+2%5804.0005297.113+10%4305.650+35%4324.785+34%3613.945+61%
Price To Free Cash Flow Ratio-813.659-3%-793.414-249.401-69%-34.556-96%-61.765-92%-24.390-97%
Price To Total Gains Ratio67.732+2%66.04761.210+8%78.044-15%67.703-2%-1853.662+2907%
Quick Ratio--2.4942.429+3%1.666+50%1.642+52%1.524+64%
Return On Assets--0.0370.038-2%0.042-11%0.028+30%0.024+51%
Return On Equity--0.0510.052-1%0.060-14%0.042+24%0.039+32%
Total Gains Per Share--87.87788.2610%66.599+32%58.665+50%43.651+101%
Usd Book Value--3214200000.0002997171000.000+7%2481828000.000+30%2275088400.000+41%1847883300.000+74%
Usd Book Value Change Per Share--1.0550.850+24%0.545+93%0.475+122%0.332+218%
Usd Book Value Per Share--19.27317.986+7%14.904+29%13.660+41%11.045+74%
Usd Dividend Per Share---0.209-100%0.254-100%0.229-100%0.192-100%
Usd Eps--0.9920.941+5%0.654+52%0.575+73%0.435+128%
Usd Free Cash Flow---3660000.00086076000.000-104%66129000.000-106%64178400.000-106%45714600.000-108%
Usd Free Cash Flow Per Share---0.0220.517-104%0.397-106%0.385-106%0.273-108%
Usd Free Cash Flow To Equity Per Share--0.3580.381-6%-0.204+157%0.099+262%0.043+728%
Usd Market Cap11893867154.400+2%11615581416.96010592676201.177+10%8603825391.600+35%8643591570.935+34%7263941776.291+60%
Usd Price Per Share71.425+2%69.64863.565+10%51.668+35%51.897+34%43.367+61%
Usd Profit--165468000.000156618000.000+6%148500000.000+11%99287400.000+67%74634900.000+122%
Usd Revenue--865776000.000813909000.000+6%705195000.000+23%642527400.000+35%541532100.000+60%
Usd Total Gains Per Share--1.0551.0590%0.799+32%0.704+50%0.524+101%
 EOD+5 -3MRQTTM+17 -19YOY+23 -125Y+29 -710Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Dr. Reddy's Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.997
Price to Book Ratio (EOD)Between0-13.706
Net Profit Margin (MRQ)Greater than00.191
Operating Margin (MRQ)Greater than00.243
Quick Ratio (MRQ)Greater than12.494
Current Ratio (MRQ)Greater than12.548
Debt to Asset Ratio (MRQ)Less than10.282
Debt to Equity Ratio (MRQ)Less than10.392
Return on Equity (MRQ)Greater than0.150.051
Return on Assets (MRQ)Greater than0.050.037
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Dr. Reddy's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.474
Ma 20Greater thanMa 506,105.205
Ma 50Greater thanMa 1006,227.118
Ma 100Greater thanMa 2005,997.993
OpenGreater thanClose6,050.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets372,842,000
Total Liabilities104,992,000
Total Stockholder Equity267,850,000
 As reported
Total Liabilities 104,992,000
Total Stockholder Equity+ 267,850,000
Total Assets = 372,842,000

Assets

Total Assets372,842,000
Total Current Assets238,477,000
Long-term Assets134,365,000
Total Current Assets
Cash And Cash Equivalents 7,342,000
Short-term Investments 65,015,000
Net Receivables 96,078,000
Inventory 60,796,000
Other Current Assets 4,215,000
Total Current Assets  (as reported)238,477,000
Total Current Assets  (calculated)233,446,000
+/- 5,031,000
Long-term Assets
Property Plant Equipment 72,795,000
Goodwill 4,287,000
Long Term Investments 8,333,000
Intangible Assets 36,905,000
Long-term Assets Other 1,128,000
Long-term Assets  (as reported)134,365,000
Long-term Assets  (calculated)123,448,000
+/- 10,917,000

Liabilities & Shareholders' Equity

Total Current Liabilities93,600,000
Long-term Liabilities11,392,000
Total Stockholder Equity267,850,000
Total Current Liabilities
Short-term Debt 13,699,000
Short Long Term Debt 12,343,000
Accounts payable 31,113,000
Other Current Liabilities 46,519,000
Total Current Liabilities  (as reported)93,600,000
Total Current Liabilities  (calculated)103,674,000
+/- 10,074,000
Long-term Liabilities
Long term Debt 3,800,000
Capital Lease Obligations 3,708,000
Long-term Liabilities Other 2,746,000
Long-term Liabilities  (as reported)11,392,000
Long-term Liabilities  (calculated)10,254,000
+/- 1,138,000
Total Stockholder Equity
Common Stock834,000
Retained Earnings 252,078,000
Accumulated Other Comprehensive Income 762,000
Other Stockholders Equity 14,176,000
Total Stockholder Equity (as reported)267,850,000
Total Stockholder Equity (calculated)267,850,000
+/-0
Other
Capital Stock834,000
Cash and Short Term Investments 72,357,000
Common Stock Shares Outstanding 166,776
Current Deferred Revenue2,269,000
Liabilities and Stockholders Equity 372,842,000
Net Debt 12,509,000
Net Invested Capital 283,993,000
Net Working Capital 144,877,000
Short Long Term Debt Total 19,851,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-30
> Total Assets 
15,389,864
17,076,874
17,984,722
18,946,182
20,888,503
21,404,831
22,290,263
23,025,311
24,349,257
25,187,277
25,646,575
26,677,051
29,104,919
27,955,321
26,100,521
29,288,339
30,941,695
31,666,211
32,814,219
68,945,818
77,626,894
82,783,210
87,091,338
86,122,732
78,354,100
80,845,591
80,180,161
85,445,040
90,995,560
95,568,333
96,341,000
83,792,000
76,229,000
82,677,000
72,617,000
80,330,000
81,865,000
83,369,000
84,021,000
95,005,000
97,951,000
107,803,000
122,430,000
119,477,000
126,634,000
130,550,000
136,811,000
142,369,000
150,936,000
161,146,000
168,119,000
170,223,000
173,544,000
176,318,000
184,399,000
194,762,000
201,200,000
202,487,000
207,882,000
207,650,000
195,525,000
220,415,000
227,188,000
219,821,000
218,387,000
222,018,000
225,956,000
225,604,000
230,880,000
234,234,000
226,675,000
225,427,000
227,090,000
233,861,000
217,898,000
232,241,000
251,243,000
253,377,000
252,346,000
265,491,000
278,214,000
278,500,000
282,499,000
295,975,000
295,975,000
290,974,000
309,300,000
322,851,000
335,041,000
347,022,000
372,842,000
372,842,000347,022,000335,041,000322,851,000309,300,000290,974,000295,975,000295,975,000282,499,000278,500,000278,214,000265,491,000252,346,000253,377,000251,243,000232,241,000217,898,000233,861,000227,090,000225,427,000226,675,000234,234,000230,880,000225,604,000225,956,000222,018,000218,387,000219,821,000227,188,000220,415,000195,525,000207,650,000207,882,000202,487,000201,200,000194,762,000184,399,000176,318,000173,544,000170,223,000168,119,000161,146,000150,936,000142,369,000136,811,000130,550,000126,634,000119,477,000122,430,000107,803,00097,951,00095,005,00084,021,00083,369,00081,865,00080,330,00072,617,00082,677,00076,229,00083,792,00096,341,00095,568,33390,995,56085,445,04080,180,16180,845,59178,354,10086,122,73287,091,33882,783,21077,626,89468,945,81832,814,21931,666,21130,941,69529,288,33926,100,52127,955,32129,104,91926,677,05125,646,57525,187,27724,349,25723,025,31122,290,26321,404,83120,888,50318,946,18217,984,72217,076,87415,389,864
   > Total Current Assets 
8,881,362
10,516,932
11,328,000
11,866,343
13,306,201
13,668,503
14,399,568
15,083,414
16,105,070
16,481,602
15,013,607
15,702,907
17,432,873
16,181,652
15,242,391
18,352,837
20,039,695
21,051,030
19,083,704
20,141,922
25,628,545
29,340,972
37,053,840
37,555,188
31,124,036
33,124,461
33,503,683
34,620,200
33,785,101
37,919,515
38,113,000
39,010,000
33,491,000
37,752,000
37,315,000
42,063,000
42,480,000
42,239,000
41,249,000
47,593,000
48,510,000
56,899,000
71,859,000
69,952,000
74,675,000
78,835,000
82,950,000
85,714,000
91,736,000
97,165,000
101,877,000
103,747,000
105,811,000
107,375,000
111,700,000
119,838,000
115,929,000
116,227,000
119,327,000
119,688,000
102,036,000
100,157,000
105,363,000
100,375,000
100,007,000
103,008,000
109,491,000
109,645,000
114,897,000
115,610,000
112,912,000
114,501,000
115,562,000
120,085,000
117,254,000
130,370,000
132,937,000
135,006,000
133,418,000
148,249,000
158,776,000
163,272,000
166,829,000
179,708,000
179,708,000
175,606,000
194,487,000
204,255,000
210,259,000
217,695,000
238,477,000
238,477,000217,695,000210,259,000204,255,000194,487,000175,606,000179,708,000179,708,000166,829,000163,272,000158,776,000148,249,000133,418,000135,006,000132,937,000130,370,000117,254,000120,085,000115,562,000114,501,000112,912,000115,610,000114,897,000109,645,000109,491,000103,008,000100,007,000100,375,000105,363,000100,157,000102,036,000119,688,000119,327,000116,227,000115,929,000119,838,000111,700,000107,375,000105,811,000103,747,000101,877,00097,165,00091,736,00085,714,00082,950,00078,835,00074,675,00069,952,00071,859,00056,899,00048,510,00047,593,00041,249,00042,239,00042,480,00042,063,00037,315,00037,752,00033,491,00039,010,00038,113,00037,919,51533,785,10134,620,20033,503,68333,124,46131,124,03637,555,18837,053,84029,340,97225,628,54520,141,92219,083,70421,051,03020,039,69518,352,83715,242,39116,181,65217,432,87315,702,90715,013,60716,481,60216,105,07015,083,41414,399,56813,668,50313,306,20111,866,34311,328,00010,516,9328,881,362
       Cash And Cash Equivalents 
3,147,794
3,088,398
4,028,096
5,103,764
6,273,680
6,490,435
6,888,633
7,252,513
7,612,977
7,613,593
5,781,050
4,385,727
4,133,333
5,534,908
5,705,522
9,287,860
10,363,956
10,565,645
8,138,998
3,722,217
3,443,230
4,858,901
16,642,153
18,024,062
11,112,817
8,429,161
6,250,069
7,398,280
3,723,929
5,120,446
3,784,000
5,596,000
6,184,000
6,149,000
5,539,000
6,584,000
6,366,000
6,196,000
4,126,000
5,729,000
5,468,000
7,596,000
16,587,000
7,379,000
8,466,000
6,979,000
8,782,000
5,136,000
9,077,000
11,521,000
21,235,000
8,451,000
6,510,000
8,216,000
6,278,000
5,394,000
6,296,000
6,681,000
5,903,000
4,921,000
6,334,000
2,443,000
6,031,000
3,866,000
2,825,000
2,460,000
2,010,000
2,638,000
2,192,000
3,780,000
1,712,000
2,228,000
2,067,000
3,012,000
2,244,000
2,053,000
4,400,000
3,889,000
4,321,000
14,829,000
8,168,000
9,980,000
21,976,000
6,018,000
6,018,000
9,096,000
6,259,000
5,779,000
6,017,000
13,391,000
7,342,000
7,342,00013,391,0006,017,0005,779,0006,259,0009,096,0006,018,0006,018,00021,976,0009,980,0008,168,00014,829,0004,321,0003,889,0004,400,0002,053,0002,244,0003,012,0002,067,0002,228,0001,712,0003,780,0002,192,0002,638,0002,010,0002,460,0002,825,0003,866,0006,031,0002,443,0006,334,0004,921,0005,903,0006,681,0006,296,0005,394,0006,278,0008,216,0006,510,0008,451,00021,235,00011,521,0009,077,0005,136,0008,782,0006,979,0008,466,0007,379,00016,587,0007,596,0005,468,0005,729,0004,126,0006,196,0006,366,0006,584,0005,539,0006,149,0006,184,0005,596,0003,784,0005,120,4463,723,9297,398,2806,250,0698,429,16111,112,81718,024,06216,642,1534,858,9013,443,2303,722,2178,138,99810,565,64510,363,9569,287,8605,705,5225,534,9084,133,3334,385,7275,781,0507,613,5937,612,9777,252,5136,888,6336,490,4356,273,6805,103,7644,028,0963,088,3983,147,794
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
500,000
2,541,735
3,915,540
1,085,046
900,000
310,873
160,696
0
14,544
14,749
14,934
14,994
15,150
15,380
15,856
1,710,851
4,224,770
4,753,600
0
0
16,000
530,000
0
50,000
1,972,000
4,173,000
2,350,000
40,000
1,022,000
33,000
84,000
1,828,000
1,899,000
10,773,000
12,887,000
13,662,000
14,482,000
16,963,000
20,829,000
15,681,000
9,967,000
25,083,000
26,440,000
20,521,000
22,458,000
34,259,000
28,821,000
27,369,000
32,125,000
35,034,000
19,244,000
18,936,000
14,114,000
14,270,000
11,748,000
14,333,000
19,948,000
18,330,000
13,413,000
15,605,000
23,062,000
22,529,000
24,628,000
25,540,000
17,505,000
23,687,000
23,291,000
21,154,000
11,530,000
19,744,000
20,331,000
14,601,000
13,224,000
28,324,000
28,324,000
18,479,000
42,241,000
60,969,000
53,032,000
54,390,000
65,015,000
65,015,00054,390,00053,032,00060,969,00042,241,00018,479,00028,324,00028,324,00013,224,00014,601,00020,331,00019,744,00011,530,00021,154,00023,291,00023,687,00017,505,00025,540,00024,628,00022,529,00023,062,00015,605,00013,413,00018,330,00019,948,00014,333,00011,748,00014,270,00014,114,00018,936,00019,244,00035,034,00032,125,00027,369,00028,821,00034,259,00022,458,00020,521,00026,440,00025,083,0009,967,00015,681,00020,829,00016,963,00014,482,00013,662,00012,887,00010,773,0001,899,0001,828,00084,00033,0001,022,00040,0002,350,0004,173,0001,972,00050,0000530,00016,000004,753,6004,224,7701,710,85115,85615,38015,15014,99414,93414,74914,5440160,696310,873900,0001,085,0463,915,5402,541,735500,0000000000000
       Net Receivables 
2,633,223
4,441,382
3,920,626
3,825,996
3,567,134
3,790,000
3,825,803
3,609,621
4,182,326
4,226,911
4,149,954
3,760,694
4,163,356
4,092,706
3,714,565
3,587,292
3,932,869
4,357,083
4,510,108
4,814,188
9,667,647
9,794,237
6,043,726
7,682,118
7,139,813
8,546,678
7,768,057
6,896,240
13,750,264
10,375,245
12,910,000
19,658,000
13,374,000
18,417,000
16,897,000
17,935,000
19,313,000
13,889,000
20,857,000
22,441,000
17,614,000
21,243,000
27,039,000
30,037,000
25,406,000
26,755,000
27,180,000
38,548,000
29,836,000
34,327,000
35,192,000
42,320,000
36,395,000
38,231,000
41,125,000
50,414,000
42,626,000
43,050,000
43,343,000
50,268,000
36,763,000
38,721,000
42,724,000
49,150,000
44,657,000
45,931,000
46,471,000
54,767,000
51,681,000
49,420,000
40,758,000
50,030,000
40,361,000
43,649,000
47,394,000
61,754,000
49,069,000
52,283,000
55,142,000
61,683,000
63,529,000
71,785,000
66,007,000
76,955,000
76,955,000
80,052,000
77,338,000
72,485,000
77,248,000
89,693,000
96,078,000
96,078,00089,693,00077,248,00072,485,00077,338,00080,052,00076,955,00076,955,00066,007,00071,785,00063,529,00061,683,00055,142,00052,283,00049,069,00061,754,00047,394,00043,649,00040,361,00050,030,00040,758,00049,420,00051,681,00054,767,00046,471,00045,931,00044,657,00049,150,00042,724,00038,721,00036,763,00050,268,00043,343,00043,050,00042,626,00050,414,00041,125,00038,231,00036,395,00042,320,00035,192,00034,327,00029,836,00038,548,00027,180,00026,755,00025,406,00030,037,00027,039,00021,243,00017,614,00022,441,00020,857,00013,889,00019,313,00017,935,00016,897,00018,417,00013,374,00019,658,00012,910,00010,375,24513,750,2646,896,2407,768,0578,546,6787,139,8137,682,1186,043,7269,794,2379,667,6474,814,1884,510,1084,357,0833,932,8693,587,2923,714,5654,092,7064,163,3563,760,6944,149,9544,226,9114,182,3263,609,6213,825,8033,790,0003,567,1343,825,9963,920,6264,441,3822,633,223
       Inventory 
2,456,297
2,525,359
2,634,892
2,191,887
2,543,505
2,588,599
2,699,376
2,773,365
2,895,023
3,130,618
3,135,662
3,038,221
3,305,333
3,762,294
3,385,261
3,499,607
3,670,000
4,039,207
4,381,107
6,912,530
8,800,993
9,864,455
8,567,422
7,563,442
8,441,882
9,602,024
10,335,146
11,132,840
13,042,846
15,377,021
15,157,000
13,226,000
13,933,000
13,136,000
12,907,000
13,371,000
14,451,000
14,728,000
15,244,000
16,059,000
17,401,000
18,592,000
19,586,000
19,352,000
20,580,000
21,885,000
23,169,000
21,600,000
22,536,000
23,874,000
24,150,000
23,992,000
25,319,000
28,123,000
29,038,000
25,529,000
26,149,000
27,147,000
26,689,000
25,578,000
27,922,000
28,516,000
30,052,000
28,529,000
28,095,000
26,998,000
26,825,000
29,089,000
31,498,000
32,490,000
33,911,000
33,579,000
35,137,000
35,033,000
37,746,000
35,066,000
39,148,000
41,134,000
44,309,000
45,412,000
50,771,000
49,700,000
49,675,000
51,810,000
51,810,000
49,042,000
49,326,000
48,670,000
52,398,000
56,592,000
60,796,000
60,796,00056,592,00052,398,00048,670,00049,326,00049,042,00051,810,00051,810,00049,675,00049,700,00050,771,00045,412,00044,309,00041,134,00039,148,00035,066,00037,746,00035,033,00035,137,00033,579,00033,911,00032,490,00031,498,00029,089,00026,825,00026,998,00028,095,00028,529,00030,052,00028,516,00027,922,00025,578,00026,689,00027,147,00026,149,00025,529,00029,038,00028,123,00025,319,00023,992,00024,150,00023,874,00022,536,00021,600,00023,169,00021,885,00020,580,00019,352,00019,586,00018,592,00017,401,00016,059,00015,244,00014,728,00014,451,00013,371,00012,907,00013,136,00013,933,00013,226,00015,157,00015,377,02113,042,84611,132,84010,335,1469,602,0248,441,8827,563,4428,567,4229,864,4558,800,9936,912,5304,381,1074,039,2073,670,0003,499,6073,385,2613,762,2943,305,3333,038,2213,135,6623,130,6182,895,0232,773,3652,699,3762,588,5992,543,5052,191,8872,634,8922,525,3592,456,297
       Other Current Assets 
644,047
461,793
744,386
744,695
921,881
799,469
985,755
1,447,915
1,414,744
1,510,481
1,446,941
1,976,529
1,915,310
1,706,697
1,537,043
1,667,205
1,912,174
2,089,095
2,038,948
4,678,237
3,701,742
4,808,386
5,785,389
4,270,186
4,413,668
4,835,747
4,925,641
4,439,240
3,268,062
7,046,803
6,246,000
0
0
0
0
0
0
7,386,000
0
3,331,000
7,943,000
7,640,000
6,748,000
2,411,000
7,336,000
9,554,000
9,337,000
3,467,000
9,458,000
11,762,000
11,333,000
3,901,000
11,147,000
12,284,000
12,801,000
4,242,000
12,037,000
11,980,000
11,267,000
3,887,000
11,773,000
11,541,000
12,442,000
4,560,000
12,682,000
13,286,000
14,237,000
4,821,000
16,113,000
14,315,000
13,469,000
6,135,000
13,369,000
12,851,000
12,365,000
7,810,000
17,029,000
16,546,000
18,116,000
6,581,000
15,977,000
17,206,000
15,947,000
16,206,000
16,206,000
18,329,000
19,142,000
15,120,000
18,512,000
1,000
4,215,000
4,215,0001,00018,512,00015,120,00019,142,00018,329,00016,206,00016,206,00015,947,00017,206,00015,977,0006,581,00018,116,00016,546,00017,029,0007,810,00012,365,00012,851,00013,369,0006,135,00013,469,00014,315,00016,113,0004,821,00014,237,00013,286,00012,682,0004,560,00012,442,00011,541,00011,773,0003,887,00011,267,00011,980,00012,037,0004,242,00012,801,00012,284,00011,147,0003,901,00011,333,00011,762,0009,458,0003,467,0009,337,0009,554,0007,336,0002,411,0006,748,0007,640,0007,943,0003,331,00007,386,0000000006,246,0007,046,8033,268,0624,439,2404,925,6414,835,7474,413,6684,270,1865,785,3894,808,3863,701,7424,678,2372,038,9482,089,0951,912,1741,667,2051,537,0431,706,6971,915,3101,976,5291,446,9411,510,4811,414,7441,447,915985,755799,469921,881744,695744,386461,793644,047
   > Long-term Assets 
6,508,501
6,559,943
6,656,723
7,079,840
7,582,302
7,736,329
7,890,695
7,941,897
8,244,186
8,705,675
10,632,968
10,974,144
11,672,046
11,773,670
10,858,130
10,935,502
10,902,000
10,615,181
13,730,514
48,803,896
51,998,349
53,442,238
50,037,498
48,567,543
47,230,064
47,721,129
46,676,477
50,824,840
57,210,459
57,648,818
58,228,000
44,782,000
42,738,000
44,925,000
35,302,000
38,267,000
39,385,000
41,130,000
42,772,000
47,412,000
49,441,000
50,904,000
50,571,000
49,525,000
51,959,000
51,715,000
53,861,000
56,655,000
59,200,000
63,981,000
66,242,000
66,476,000
67,733,000
68,943,000
72,699,000
74,924,000
85,271,000
86,260,000
88,555,000
87,962,000
93,489,000
120,258,000
121,825,000
119,446,000
118,380,000
119,010,000
116,465,000
115,959,000
115,983,000
118,624,000
113,763,000
110,926,000
111,528,000
113,776,000
100,644,000
101,871,000
118,306,000
118,371,000
118,928,000
117,242,000
119,438,000
115,228,000
115,670,000
116,267,000
116,267,000
115,368,000
114,813,000
118,596,000
124,782,000
129,327,000
134,365,000
134,365,000129,327,000124,782,000118,596,000114,813,000115,368,000116,267,000116,267,000115,670,000115,228,000119,438,000117,242,000118,928,000118,371,000118,306,000101,871,000100,644,000113,776,000111,528,000110,926,000113,763,000118,624,000115,983,000115,959,000116,465,000119,010,000118,380,000119,446,000121,825,000120,258,00093,489,00087,962,00088,555,00086,260,00085,271,00074,924,00072,699,00068,943,00067,733,00066,476,00066,242,00063,981,00059,200,00056,655,00053,861,00051,715,00051,959,00049,525,00050,571,00050,904,00049,441,00047,412,00042,772,00041,130,00039,385,00038,267,00035,302,00044,925,00042,738,00044,782,00058,228,00057,648,81857,210,45950,824,84046,676,47747,721,12947,230,06448,567,54350,037,49853,442,23851,998,34948,803,89613,730,51410,615,18110,902,00010,935,50210,858,13011,773,67011,672,04610,974,14410,632,9688,705,6758,244,1867,941,8977,890,6957,736,3297,582,3027,079,8406,656,7236,559,9436,508,501
       Property Plant Equipment 
3,262,989
3,402,981
3,558,265
3,794,957
4,095,297
4,341,304
4,548,297
4,816,588
5,128,884
5,650,572
6,085,571
6,344,859
6,658,666
6,799,037
6,403,000
7,058,297
7,027,782
7,084,084
7,018,641
9,109,794
9,755,825
10,418,108
11,375,999
12,457,251
12,987,314
13,632,217
14,761,674
16,765,400
19,296,169
20,218,904
20,672,000
20,882,000
20,970,000
21,278,000
21,407,000
22,459,000
23,940,000
25,412,000
27,102,000
29,642,000
30,524,000
31,450,000
32,433,000
33,246,000
34,550,000
35,300,000
36,126,000
37,814,000
39,393,000
42,477,000
43,844,000
44,424,000
45,350,000
46,559,000
47,887,000
48,090,000
49,386,000
51,055,000
52,736,000
53,961,000
54,951,000
56,052,000
57,209,000
57,160,000
57,611,000
57,905,000
58,189,000
57,869,000
57,020,000
56,640,000
55,344,000
54,088,000
54,083,000
53,008,000
52,709,000
52,332,000
54,183,000
55,026,000
56,263,000
57,111,000
58,636,000
60,229,000
62,971,000
63,826,000
63,826,000
63,817,000
64,996,000
56,542,000
67,207,000
70,478,000
72,795,000
72,795,00070,478,00067,207,00056,542,00064,996,00063,817,00063,826,00063,826,00062,971,00060,229,00058,636,00057,111,00056,263,00055,026,00054,183,00052,332,00052,709,00053,008,00054,083,00054,088,00055,344,00056,640,00057,020,00057,869,00058,189,00057,905,00057,611,00057,160,00057,209,00056,052,00054,951,00053,961,00052,736,00051,055,00049,386,00048,090,00047,887,00046,559,00045,350,00044,424,00043,844,00042,477,00039,393,00037,814,00036,126,00035,300,00034,550,00033,246,00032,433,00031,450,00030,524,00029,642,00027,102,00025,412,00023,940,00022,459,00021,407,00021,278,00020,970,00020,882,00020,672,00020,218,90419,296,16916,765,40014,761,67413,632,21712,987,31412,457,25111,375,99910,418,1089,755,8259,109,7947,018,6417,084,0847,027,7827,058,2976,403,0006,799,0376,658,6666,344,8596,085,5715,650,5725,128,8844,816,5884,548,2974,341,3044,095,2973,794,9573,558,2653,402,9813,262,989
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,677,480
17,934,891
15,489,857
15,630,361
15,577,525
14,893,156
15,395,994
15,788,627
16,978,920
18,441,471
18,295,861
18,573,000
7,300,000
0
7,494,000
2,194,000
2,174,000
2,168,000
2,174,000
2,170,000
2,180,000
2,184,000
2,200,000
2,216,000
2,208,000
2,226,000
2,039,000
2,044,000
3,193,000
3,341,000
3,466,000
3,473,000
3,428,000
3,421,000
3,553,000
3,538,000
3,380,000
3,773,000
3,816,000
3,794,000
3,848,000
3,848,000
3,832,000
3,789,000
3,752,000
3,824,000
3,883,000
3,870,000
3,945,000
3,936,000
4,016,000
3,942,000
3,902,000
3,916,000
3,891,000
3,939,000
3,994,000
4,817,000
4,581,000
4,634,000
4,568,000
4,615,000
4,576,000
4,546,000
4,381,000
4,381,000
4,328,000
4,495,000
5,474,000
4,238,000
4,223,000
4,287,000
4,287,0004,223,0004,238,0005,474,0004,495,0004,328,0004,381,0004,381,0004,546,0004,576,0004,615,0004,568,0004,634,0004,581,0004,817,0003,994,0003,939,0003,891,0003,916,0003,902,0003,942,0004,016,0003,936,0003,945,0003,870,0003,883,0003,824,0003,752,0003,789,0003,832,0003,848,0003,848,0003,794,0003,816,0003,773,0003,380,0003,538,0003,553,0003,421,0003,428,0003,473,0003,466,0003,341,0003,193,0002,044,0002,039,0002,226,0002,208,0002,216,0002,200,0002,184,0002,180,0002,170,0002,174,0002,168,0002,174,0002,194,0007,494,00007,300,00018,573,00018,295,86118,441,47116,978,92015,788,62715,395,99414,893,15615,577,52515,630,36115,489,85717,934,89116,677,4800000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,389,000
6,840,000
5,366,000
4,831,000
5,014,000
4,653,000
3,626,000
3,781,000
3,159,000
3,342,000
3,975,000
4,217,000
3,278,000
3,091,000
3,387,000
3,992,000
8,632,000
8,333,000
9,496,000
7,489,000
6,491,000
7,986,000
5,214,000
6,107,000
6,279,000
6,089,000
4,904,000
5,924,000
8,333,000
8,333,0005,924,0004,904,0006,089,0006,279,0006,107,0005,214,0007,986,0006,491,0007,489,0009,496,0008,333,0008,632,0003,992,0003,387,0003,091,0003,278,0004,217,0003,975,0003,342,0003,159,0003,781,0003,626,0004,653,0005,014,0004,831,0005,366,0006,840,0007,389,00000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
2,774,821
2,682,030
2,638,361
2,862,273
3,075,425
2,998,986
2,932,806
2,859,337
2,822,744
2,733,867
2,750,411
2,671,410
4,641,609
3,025,505
2,719,870
2,588,384
2,575,000
2,509,252
2,441,533
17,078,559
18,234,665
21,438,464
21,290,225
18,933,165
17,661,501
17,686,531
15,605,784
16,622,640
19,094,986
18,742,869
18,567,000
14,879,000
0
14,563,000
10,221,000
11,799,000
11,119,000
11,337,000
10,847,000
13,066,000
12,737,000
12,915,000
12,966,000
11,321,000
11,371,000
10,258,000
10,392,000
10,828,000
11,445,000
11,808,000
12,212,000
11,269,000
10,856,000
10,095,000
14,282,000
13,050,000
20,333,000
20,339,000
20,945,000
20,796,000
24,436,000
46,934,000
46,188,000
44,925,000
44,740,000
45,751,000
44,312,000
44,665,000
45,353,000
47,274,000
45,263,000
44,367,000
43,905,000
40,449,000
26,908,000
27,659,000
41,174,000
40,972,000
36,428,000
35,648,000
35,131,000
32,630,000
32,035,000
31,832,000
31,832,000
31,756,000
30,906,000
30,724,000
38,068,000
37,055,000
36,905,000
36,905,00037,055,00038,068,00030,724,00030,906,00031,756,00031,832,00031,832,00032,035,00032,630,00035,131,00035,648,00036,428,00040,972,00041,174,00027,659,00026,908,00040,449,00043,905,00044,367,00045,263,00047,274,00045,353,00044,665,00044,312,00045,751,00044,740,00044,925,00046,188,00046,934,00024,436,00020,796,00020,945,00020,339,00020,333,00013,050,00014,282,00010,095,00010,856,00011,269,00012,212,00011,808,00011,445,00010,828,00010,392,00010,258,00011,371,00011,321,00012,966,00012,915,00012,737,00013,066,00010,847,00011,337,00011,119,00011,799,00010,221,00014,563,000014,879,00018,567,00018,742,86919,094,98616,622,64015,605,78417,686,53117,661,50118,933,16521,290,22521,438,46418,234,66517,078,5592,441,5332,509,2522,575,0002,588,3842,719,8703,025,5054,641,6092,671,4102,750,4112,733,8672,822,7442,859,3372,932,8062,998,9863,075,4252,862,2732,638,3612,682,0302,774,821
       Long-term Assets Other 
470,692
474,932
460,096
422,609
411,579
396,039
409,592
265,972
292,558
321,236
1,796,986
1,957,874
371,770
1,949,128
1,735,261
1,288,821
1,299,217
1,021,845
4,270,341
5,938,063
6,072,968
6,095,809
1,740,912
1,599,602
1,688,092
1,006,388
520,392
457,880
139,246
150,636
169,000
200,000
21,768,000
186,000
177,000
243,000
259,000
267,000
282,000
276,000
316,000
366,000
400,000
417,000
516,000
632,000
660,000
487,000
509,000
576,000
586,000
495,000
546,000
819,000
798,000
762,000
837,000
838,000
882,000
1,063,000
1,052,000
1,076,000
1,148,000
1,189,000
1,213,000
1,269,000
1,182,000
1,199,000
1,207,000
1,349,000
1,145,000
1,059,000
1,044,000
2,352,000
2,568,000
2,581,000
2,552,000
1,143,000
1,133,000
952,000
968,000
882,000
999,000
1,877,000
1,877,000
1,801,000
1,831,000
12,715,000
821,000
812,000
1,128,000
1,128,000812,000821,00012,715,0001,831,0001,801,0001,877,0001,877,000999,000882,000968,000952,0001,133,0001,143,0002,552,0002,581,0002,568,0002,352,0001,044,0001,059,0001,145,0001,349,0001,207,0001,199,0001,182,0001,269,0001,213,0001,189,0001,148,0001,076,0001,052,0001,063,000882,000838,000837,000762,000798,000819,000546,000495,000586,000576,000509,000487,000660,000632,000516,000417,000400,000366,000316,000276,000282,000267,000259,000243,000177,000186,00021,768,000200,000169,000150,636139,246457,880520,3921,006,3881,688,0921,599,6021,740,9126,095,8096,072,9685,938,0634,270,3411,021,8451,299,2171,288,8211,735,2611,949,128371,7701,957,8741,796,986321,236292,558265,972409,592396,039411,579422,609460,096474,932470,692
> Total Liabilities 
3,832,244
3,565,528
3,540,385
3,505,713
4,175,768
3,918,454
4,065,851
4,247,583
4,603,349
4,962,334
4,825,434
5,592,061
7,881,103
6,578,073
6,315,217
8,335,196
9,605,913
9,839,259
10,339,772
46,616,524
53,538,394
56,367,353
48,538,845
44,435,475
35,171,440
35,566,437
35,212,317
38,378,440
41,700,631
45,874,559
44,491,000
41,747,000
31,397,000
37,029,000
32,084,000
37,415,000
36,899,000
38,124,000
35,870,000
49,015,000
49,049,000
59,722,000
70,504,000
62,033,000
66,970,000
67,345,000
70,022,000
69,264,000
75,885,000
83,060,000
82,951,000
79,422,000
76,814,000
77,314,000
79,292,000
83,460,000
82,315,000
80,988,000
79,201,000
79,314,000
81,413,000
105,151,000
106,148,000
95,777,000
94,964,000
100,178,000
102,271,000
99,144,000
100,450,000
102,788,000
90,967,000
85,230,000
80,882,000
80,045,000
69,226,000
77,253,000
89,495,000
88,040,000
82,951,000
92,429,000
100,100,000
94,572,000
92,483,000
95,586,000
95,586,000
84,749,000
89,027,000
89,990,000
89,781,000
93,936,000
104,992,000
104,992,00093,936,00089,781,00089,990,00089,027,00084,749,00095,586,00095,586,00092,483,00094,572,000100,100,00092,429,00082,951,00088,040,00089,495,00077,253,00069,226,00080,045,00080,882,00085,230,00090,967,000102,788,000100,450,00099,144,000102,271,000100,178,00094,964,00095,777,000106,148,000105,151,00081,413,00079,314,00079,201,00080,988,00082,315,00083,460,00079,292,00077,314,00076,814,00079,422,00082,951,00083,060,00075,885,00069,264,00070,022,00067,345,00066,970,00062,033,00070,504,00059,722,00049,049,00049,015,00035,870,00038,124,00036,899,00037,415,00032,084,00037,029,00031,397,00041,747,00044,491,00045,874,55941,700,63138,378,44035,212,31735,566,43735,171,44044,435,47548,538,84556,367,35353,538,39446,616,52410,339,7729,839,2599,605,9138,335,1966,315,2176,578,0737,881,1035,592,0614,825,4344,962,3344,603,3494,247,5834,065,8513,918,4544,175,7683,505,7133,540,3853,565,5283,832,244
   > Total Current Liabilities 
2,815,083
2,429,847
2,291,470
2,358,144
2,829,815
2,586,860
2,719,808
3,094,503
3,500,372
3,833,821
3,752,466
4,575,575
7,077,425
5,748,991
5,654,782
7,581,921
8,778,304
9,096,611
9,399,928
18,793,290
24,648,487
26,915,842
24,039,971
18,577,352
15,138,592
16,992,899
17,521,298
19,392,280
23,273,367
28,694,249
28,323,000
26,553,000
0
24,024,000
21,923,000
29,022,000
29,970,000
33,010,000
33,042,000
41,015,000
40,888,000
51,534,000
51,597,000
43,460,000
47,400,000
47,531,000
49,744,000
53,646,000
59,542,000
55,013,000
56,557,000
54,063,000
52,943,000
54,733,000
58,481,000
63,995,000
64,626,000
65,491,000
63,271,000
64,646,000
67,209,000
89,487,000
95,281,000
85,000,000
65,520,000
70,339,000
73,198,000
69,692,000
70,262,000
71,306,000
62,560,000
59,700,000
60,980,000
61,176,000
64,694,000
72,814,000
79,884,000
78,569,000
73,872,000
83,391,000
91,525,000
85,902,000
83,654,000
90,791,000
90,791,000
80,031,000
84,383,000
85,721,000
80,767,000
84,183,000
93,600,000
93,600,00084,183,00080,767,00085,721,00084,383,00080,031,00090,791,00090,791,00083,654,00085,902,00091,525,00083,391,00073,872,00078,569,00079,884,00072,814,00064,694,00061,176,00060,980,00059,700,00062,560,00071,306,00070,262,00069,692,00073,198,00070,339,00065,520,00085,000,00095,281,00089,487,00067,209,00064,646,00063,271,00065,491,00064,626,00063,995,00058,481,00054,733,00052,943,00054,063,00056,557,00055,013,00059,542,00053,646,00049,744,00047,531,00047,400,00043,460,00051,597,00051,534,00040,888,00041,015,00033,042,00033,010,00029,970,00029,022,00021,923,00024,024,000026,553,00028,323,00028,694,24923,273,36719,392,28017,521,29816,992,89915,138,59218,577,35224,039,97126,915,84224,648,48718,793,2909,399,9289,096,6118,778,3047,581,9215,654,7825,748,9917,077,4254,575,5753,752,4663,833,8213,500,3723,094,5032,719,8082,586,8602,829,8152,358,1442,291,4702,429,8472,815,083
       Short-term Debt 
0
0
0
0
0
0
5,947
289,289
147,349
147,277
154,840
474,273
2,344,230
1,438,211
2,021,130
2,802,271
3,923,783
4,115,819
3,837,228
10,084,217
11,583,330
11,713,029
12,561,768
6,899,252
2,917,876
4,032,930
4,900,224
6,677,520
6,017,071
10,220,540
11,027,000
9,569,000
0
6,321,000
5,702,000
9,310,000
9,646,000
12,122,000
13,575,000
18,301,000
18,654,000
26,009,000
21,691,000
15,875,000
18,032,000
18,078,000
19,502,000
24,135,000
30,152,000
24,130,000
26,351,000
24,002,000
22,614,000
20,968,000
23,225,000
28,819,000
29,317,000
26,441,000
23,108,000
22,828,000
26,785,000
49,803,000
52,282,000
43,736,000
25,902,000
28,715,000
30,450,000
25,625,000
28,176,000
27,925,000
19,136,000
16,381,000
17,732,000
16,261,000
15,074,000
20,798,000
24,793,000
20,768,000
13,935,000
24,009,000
27,207,000
24,296,000
22,131,000
22,763,000
22,763,000
15,494,000
16,206,000
12,194,000
7,590,000
7,187,000
13,699,000
13,699,0007,187,0007,590,00012,194,00016,206,00015,494,00022,763,00022,763,00022,131,00024,296,00027,207,00024,009,00013,935,00020,768,00024,793,00020,798,00015,074,00016,261,00017,732,00016,381,00019,136,00027,925,00028,176,00025,625,00030,450,00028,715,00025,902,00043,736,00052,282,00049,803,00026,785,00022,828,00023,108,00026,441,00029,317,00028,819,00023,225,00020,968,00022,614,00024,002,00026,351,00024,130,00030,152,00024,135,00019,502,00018,078,00018,032,00015,875,00021,691,00026,009,00018,654,00018,301,00013,575,00012,122,0009,646,0009,310,0005,702,0006,321,00009,569,00011,027,00010,220,5406,017,0716,677,5204,900,2244,032,9302,917,8766,899,25212,561,76811,713,02911,583,33010,084,2173,837,2284,115,8193,923,7832,802,2712,021,1301,438,2112,344,230474,273154,840147,277147,349289,2895,947000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,999,000
49,185,000
50,462,000
53,667,000
54,911,000
50,714,000
54,273,000
0
1,818,000
16,324,000
17,078,000
15,621,000
14,467,000
20,315,000
24,049,000
19,953,000
13,110,000
24,009,000
26,299,000
24,296,000
21,331,000
28,099,000
21,701,000
14,573,000
15,268,000
12,194,000
6,468,000
5,851,000
12,343,000
12,343,0005,851,0006,468,00012,194,00015,268,00014,573,00021,701,00028,099,00021,331,00024,296,00026,299,00024,009,00013,110,00019,953,00024,049,00020,315,00014,467,00015,621,00017,078,00016,324,0001,818,000054,273,00050,714,00054,911,00053,667,00050,462,00049,185,00057,999,00000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,355,041
972,178
1,057,735
1,121,403
1,546,912
1,511,546
1,620,192
1,680,522
2,022,791
2,166,957
2,105,068
2,179,002
2,258,805
2,258,853
1,597,783
1,415,633
1,838,478
1,876,577
2,148,859
3,648,605
7,734,596
9,583,948
5,663,575
4,766,233
5,317,965
5,944,495
5,308,902
5,409,800
7,769,106
8,194,217
6,716,000
5,987,000
6,873,000
7,198,000
5,914,000
9,322,000
9,689,000
9,907,000
7,395,000
8,480,000
8,433,000
8,940,000
9,189,000
9,502,000
8,750,000
10,412,000
10,996,000
118,618,000
10,076,000
10,828,000
9,744,000
10,503,000
10,640,000
12,843,000
12,333,000
10,660,000
11,448,000
12,766,000
11,833,000
12,300,000
12,723,000
12,281,000
13,308,000
13,417,000
13,225,000
14,193,000
14,575,000
16,052,000
14,816,000
14,073,000
15,939,000
10,296,000
14,842,000
15,434,000
17,810,000
10,745,000
19,038,000
22,833,000
23,072,000
12,696,000
28,607,000
25,552,000
24,492,000
25,052,000
25,052,000
22,778,000
26,023,000
22,684,000
55,364,000
30,485,000
31,113,000
31,113,00030,485,00055,364,00022,684,00026,023,00022,778,00025,052,00025,052,00024,492,00025,552,00028,607,00012,696,00023,072,00022,833,00019,038,00010,745,00017,810,00015,434,00014,842,00010,296,00015,939,00014,073,00014,816,00016,052,00014,575,00014,193,00013,225,00013,417,00013,308,00012,281,00012,723,00012,300,00011,833,00012,766,00011,448,00010,660,00012,333,00012,843,00010,640,00010,503,0009,744,00010,828,00010,076,000118,618,00010,996,00010,412,0008,750,0009,502,0009,189,0008,940,0008,433,0008,480,0007,395,0009,907,0009,689,0009,322,0005,914,0007,198,0006,873,0005,987,0006,716,0008,194,2177,769,1065,409,8005,308,9025,944,4955,317,9654,766,2335,663,5759,583,9487,734,5963,648,6052,148,8591,876,5771,838,4781,415,6331,597,7832,258,8532,258,8052,179,0022,105,0682,166,9572,022,7911,680,5221,620,1921,511,5461,546,9121,121,4031,057,735972,1781,355,041
       Other Current Liabilities 
1,460,041
1,457,669
1,233,735
1,236,740
1,282,903
1,075,314
1,093,669
1,124,692
1,330,233
1,519,588
1,492,557
1,922,299
2,474,391
2,051,927
2,035,870
3,364,017
3,016,043
3,104,215
3,413,841
5,060,467
5,330,561
5,618,865
5,814,628
6,911,867
6,902,752
7,015,474
7,312,172
7,304,960
9,487,190
10,279,492
10,580,000
10,997,000
0
9,207,000
8,958,000
8,958,000
9,053,000
9,211,000
10,525,000
12,500,000
11,662,000
14,717,000
19,025,000
17,401,000
19,649,000
17,783,000
18,023,000
-90,657,000
18,176,000
18,838,000
18,731,000
17,688,000
18,333,000
19,144,000
20,589,000
20,954,000
21,567,000
23,049,000
25,087,000
26,278,000
25,547,000
25,252,000
27,523,000
25,545,000
24,809,000
25,723,000
26,648,000
25,503,000
26,409,000
28,224,000
26,682,000
31,491,000
27,896,000
29,031,000
31,322,000
38,788,000
35,184,000
33,812,000
35,345,000
43,264,000
34,350,000
34,743,000
35,443,000
42,976,000
42,976,000
35,812,000
35,922,000
48,862,000
35,672,000
43,510,000
46,519,000
46,519,00043,510,00035,672,00048,862,00035,922,00035,812,00042,976,00042,976,00035,443,00034,743,00034,350,00043,264,00035,345,00033,812,00035,184,00038,788,00031,322,00029,031,00027,896,00031,491,00026,682,00028,224,00026,409,00025,503,00026,648,00025,723,00024,809,00025,545,00027,523,00025,252,00025,547,00026,278,00025,087,00023,049,00021,567,00020,954,00020,589,00019,144,00018,333,00017,688,00018,731,00018,838,00018,176,000-90,657,00018,023,00017,783,00019,649,00017,401,00019,025,00014,717,00011,662,00012,500,00010,525,0009,211,0009,053,0008,958,0008,958,0009,207,000010,997,00010,580,00010,279,4929,487,1907,304,9607,312,1727,015,4746,902,7526,911,8675,814,6285,618,8655,330,5615,060,4673,413,8413,104,2153,016,0433,364,0172,035,8702,051,9272,474,3911,922,2991,492,5571,519,5881,330,2331,124,6921,093,6691,075,3141,282,9031,236,7401,233,7351,457,6691,460,041
   > Long-term Liabilities 
1,017,162
1,135,681
1,248,916
1,147,570
1,345,953
1,331,594
1,346,043
1,153,081
1,102,977
1,128,513
1,072,968
1,016,486
803,678
829,083
660,435
753,275
827,609
742,649
939,844
27,823,234
28,889,907
29,451,511
24,498,873
25,858,122
20,032,847
18,573,538
17,691,019
18,986,160
18,427,264
17,180,310
16,168,000
15,194,000
16,108,000
13,005,000
10,161,000
8,393,000
6,929,000
5,114,000
2,828,000
8,000,000
8,161,000
8,188,000
18,907,000
18,573,000
19,570,000
19,814,000
20,278,000
15,618,000
16,343,000
28,047,000
26,394,000
25,359,000
23,871,000
22,581,000
20,811,000
19,465,000
17,689,000
15,497,000
15,930,000
14,668,000
14,204,000
15,664,000
10,867,000
10,777,000
29,444,000
29,839,000
29,073,000
29,452,000
30,188,000
31,482,000
28,407,000
25,530,000
19,902,000
18,869,000
4,532,000
4,439,000
9,611,000
9,471,000
9,079,000
9,038,000
8,575,000
8,670,000
8,829,000
4,795,000
4,795,000
4,718,000
4,644,000
4,269,000
9,014,000
9,753,000
11,392,000
11,392,0009,753,0009,014,0004,269,0004,644,0004,718,0004,795,0004,795,0008,829,0008,670,0008,575,0009,038,0009,079,0009,471,0009,611,0004,439,0004,532,00018,869,00019,902,00025,530,00028,407,00031,482,00030,188,00029,452,00029,073,00029,839,00029,444,00010,777,00010,867,00015,664,00014,204,00014,668,00015,930,00015,497,00017,689,00019,465,00020,811,00022,581,00023,871,00025,359,00026,394,00028,047,00016,343,00015,618,00020,278,00019,814,00019,570,00018,573,00018,907,0008,188,0008,161,0008,000,0002,828,0005,114,0006,929,0008,393,00010,161,00013,005,00016,108,00015,194,00016,168,00017,180,31018,427,26418,986,16017,691,01918,573,53820,032,84725,858,12224,498,87329,451,51128,889,90727,823,234939,844742,649827,609753,275660,435829,083803,6781,016,4861,072,9681,128,5131,102,9771,153,0811,346,0431,331,5941,345,9531,147,5701,248,9161,135,6811,017,162
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,000,000
0
15,284,000
0
1,304,000
0
6,661,000
0
6,299,000
0
5,977,000
0
5,746,000
0
1,795,000
0
1,278,000
0
6,043,000
0
06,043,00001,278,00001,795,00005,746,00005,977,00006,299,00006,661,00001,304,000015,284,000022,000,00000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,328,000
4,884,000
4,887,000
4,612,000
4,363,000
4,091,000
3,885,000
3,707,000
3,530,000
3,245,000
3,585,000
3,286,000
3,135,000
2,822,000
2,810,000
2,571,000
2,739,000
2,409,000
2,693,000
2,796,000
2,539,000
2,892,000
2,923,000
3,187,000
0
4,084,000
0
0
004,084,00003,187,0002,923,0002,892,0002,539,0002,796,0002,693,0002,409,0002,739,0002,571,0002,810,0002,822,0003,135,0003,286,0003,585,0003,245,0003,530,0003,707,0003,885,0004,091,0004,363,0004,612,0004,887,0004,884,0005,328,000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
11,557,619
13,511,346
14,444,337
15,440,469
16,712,735
17,486,377
18,220,623
18,777,727
19,745,908
20,224,943
20,821,141
21,084,990
21,223,815
21,377,248
19,785,304
20,953,143
21,335,782
21,826,952
22,474,447
22,329,294
24,088,500
26,415,858
38,552,493
41,676,759
43,175,179
45,272,806
44,967,844
47,066,600
49,294,929
49,693,774
51,850,000
42,045,000
44,832,000
45,648,000
40,533,000
42,915,000
44,966,000
45,245,000
48,151,000
45,990,000
48,902,000
48,081,000
51,926,000
57,444,000
59,664,000
63,205,000
66,789,000
73,085,000
75,035,000
78,069,000
85,168,000
90,801,000
96,730,000
99,004,000
105,107,000
111,302,000
118,885,000
121,499,000
128,681,000
128,336,000
114,112,000
115,264,000
121,040,000
124,044,000
123,423,000
121,840,000
123,685,000
126,460,000
130,430,000
131,446,000
135,708,000
140,197,000
146,208,000
153,816,000
148,672,000
154,988,000
161,748,000
165,337,000
169,395,000
173,062,000
178,114,000
183,928,000
190,016,000
200,389,000
200,389,000
206,225,000
220,273,000
232,861,000
245,259,000
253,086,000
267,850,000
267,850,000253,086,000245,259,000232,861,000220,273,000206,225,000200,389,000200,389,000190,016,000183,928,000178,114,000173,062,000169,395,000165,337,000161,748,000154,988,000148,672,000153,816,000146,208,000140,197,000135,708,000131,446,000130,430,000126,460,000123,685,000121,840,000123,423,000124,044,000121,040,000115,264,000114,112,000128,336,000128,681,000121,499,000118,885,000111,302,000105,107,00099,004,00096,730,00090,801,00085,168,00078,069,00075,035,00073,085,00066,789,00063,205,00059,664,00057,444,00051,926,00048,081,00048,902,00045,990,00048,151,00045,245,00044,966,00042,915,00040,533,00045,648,00044,832,00042,045,00051,850,00049,693,77449,294,92947,066,60044,967,84445,272,80643,175,17941,676,75938,552,49326,415,85824,088,50022,329,29422,474,44721,826,95221,335,78220,953,14319,785,30421,377,24821,223,81521,084,99020,821,14120,224,94319,745,90818,777,72718,220,62317,486,37716,712,73515,440,46914,444,33713,511,34611,557,619
   Common Stock
382,275
381,045
381,639
382,166
382,738
382,560
383,501
381,469
384,372
383,478
382,603
383,427
382,483
382,615
352,652
382,576
382,696
382,796
382,548
384,458
384,184
764,948
841,350
841,534
841,810
838,881
841,431
840,880
841,487
842,004
842,000
842,000
0
844,000
844,000
844,000
846,000
846,000
846,000
846,000
847,000
848,000
848,000
848,000
849,000
849,000
849,000
849,000
850,000
850,000
850,000
851,000
852,000
852,000
852,000
852,000
853,000
853,000
853,000
853,000
828,000
829,000
829,000
829,000
829,000
829,000
829,000
830,000
830,000
830,000
830,000
830,000
831,000
831,000
831,000
831,000
831,000
831,000
831,000
832,000
832,000
832,000
833,000
832,000
832,000
832,000
833,000
833,000
833,000
834,000
834,000
834,000834,000833,000833,000833,000832,000832,000832,000833,000832,000832,000832,000831,000831,000831,000831,000831,000831,000831,000830,000830,000830,000830,000830,000829,000829,000829,000829,000829,000829,000828,000853,000853,000853,000853,000852,000852,000852,000852,000851,000850,000850,000850,000849,000849,000849,000849,000848,000848,000848,000847,000846,000846,000846,000846,000844,000844,000844,0000842,000842,000842,004841,487840,880841,431838,881841,810841,534841,350764,948384,184384,458382,548382,796382,696382,576352,652382,615382,483383,427382,603383,478384,372381,469383,501382,560382,738382,166381,639381,045382,275
   Retained Earnings 
1,067,712
3,048,263
3,937,783
4,981,021
6,201,261
6,960,677
7,671,415
8,298,863
9,020,466
9,497,712
10,067,580
10,251,844
10,400,138
10,488,486
9,704,565
10,009,301
10,356,608
10,813,326
11,433,563
11,230,728
12,621,239
14,908,501
16,882,867
20,138,764
21,956,903
23,805,357
23,024,786
24,031,880
25,322,546
25,636,732
28,082,000
18,305,000
0
21,690,000
16,398,000
18,035,000
20,131,000
20,255,000
22,986,000
20,391,000
22,807,000
23,458,000
28,373,000
31,599,000
34,748,000
35,746,000
39,314,000
44,815,000
48,213,000
51,919,000
57,887,000
65,051,000
70,555,000
72,709,000
78,454,000
83,643,000
89,900,000
93,012,000
98,804,000
99,550,000
100,838,000
100,398,000
105,099,000
108,224,000
108,642,000
107,499,000
110,843,000
113,865,000
118,414,000
119,449,000
124,301,000
128,646,000
135,288,000
142,302,000
136,605,000
144,247,000
150,040,000
152,458,000
152,185,000
156,023,000
161,761,000
167,819,000
174,914,000
187,814,000
187,814,000
194,165,000
206,714,000
215,593,000
230,020,000
238,226,000
252,078,000
252,078,000238,226,000230,020,000215,593,000206,714,000194,165,000187,814,000187,814,000174,914,000167,819,000161,761,000156,023,000152,185,000152,458,000150,040,000144,247,000136,605,000142,302,000135,288,000128,646,000124,301,000119,449,000118,414,000113,865,000110,843,000107,499,000108,642,000108,224,000105,099,000100,398,000100,838,00099,550,00098,804,00093,012,00089,900,00083,643,00078,454,00072,709,00070,555,00065,051,00057,887,00051,919,00048,213,00044,815,00039,314,00035,746,00034,748,00031,599,00028,373,00023,458,00022,807,00020,391,00022,986,00020,255,00020,131,00018,035,00016,398,00021,690,000018,305,00028,082,00025,636,73225,322,54624,031,88023,024,78623,805,35721,956,90320,138,76416,882,86714,908,50112,621,23911,230,72811,433,56310,813,32610,356,60810,009,3019,704,56510,488,48610,400,13810,251,84410,067,5809,497,7129,020,4668,298,8637,671,4156,960,6776,201,2614,981,0213,937,7833,048,2631,067,712
   Accumulated Other Comprehensive Income 
-2,122,693
-2,158,840
-2,430,458
-2,430,942
-2,562,440
-2,699,807
56,499
41,327
209,163
235,698
285,936
338,655
354,897
417,018
428,522
472,096
492,826
523,977
558,827
425,764
798,098
845,497
897,089
740,485
360,288
664,432
1,067,936
2,162,240
2,837,800
2,923,869
2,388,000
2,168,000
0
0
0
-12,087,000
0
0
0
-14,714,000
0
0
1,394,000
865,000
1,076,000
1,289,000
1,503,000
1,711,000
1,922,000
2,135,000
2,349,000
0
0
0
0
0
0
0
0
-36,179,000
0
0
0
-42,980,000
0
0
0
-50,245,000
0
0
0
-55,560,000
0
0
0
-63,311,000
0
1,059,000
1,529,000
1,326,000
1,296,000
1,012,000
982,000
833,000
833,000
631,000
553,000
1,266,000
864,000
810,000
762,000
762,000810,000864,0001,266,000553,000631,000833,000833,000982,0001,012,0001,296,0001,326,0001,529,0001,059,0000-63,311,000000-55,560,000000-50,245,000000-42,980,000000-36,179,000000000002,349,0002,135,0001,922,0001,711,0001,503,0001,289,0001,076,000865,0001,394,00000-14,714,000000-12,087,0000002,168,0002,388,0002,923,8692,837,8002,162,2401,067,936664,432360,288740,485897,089845,497798,098425,764558,827523,977492,826472,096428,522417,018354,897338,655285,936235,698209,16341,32756,499-2,699,807-2,562,440-2,430,942-2,430,458-2,158,840-2,122,693
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,688,000
0
0
0
0009,688,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
12,230,324
12,240,878
12,555,373
12,508,223
12,691,175
12,842,947
10,109,208
10,056,067
10,131,907
10,108,055
10,085,023
10,111,063
10,086,299
10,089,129
9,299,565
10,089,170
10,103,652
10,106,852
10,099,509
10,288,344
10,284,980
9,896,912
19,931,187
19,955,976
20,016,179
19,964,135
20,033,691
20,031,600
20,293,096
20,291,169
20,538,000
20,730,000
44,832,000
23,114,000
23,291,000
36,123,000
23,989,000
24,144,000
24,319,000
39,467,000
25,248,000
23,775,000
21,311,000
24,132,000
22,991,000
25,321,000
25,123,000
25,710,000
24,050,000
23,165,000
24,082,000
24,899,000
25,323,000
25,443,000
25,801,000
26,807,000
28,132,000
27,634,000
29,024,000
64,112,000
12,446,000
14,037,000
15,112,000
57,971,000
13,952,000
13,512,000
12,013,000
62,010,000
11,186,000
11,167,000
10,577,000
66,281,000
10,089,000
10,683,000
11,236,000
73,221,000
10,877,000
10,989,000
14,850,000
14,881,000
14,225,000
14,265,000
13,287,000
10,910,000
10,910,000
10,597,000
12,173,000
15,169,000
-231,717,000
13,216,000
14,176,000
14,176,00013,216,000-231,717,00015,169,00012,173,00010,597,00010,910,00010,910,00013,287,00014,265,00014,225,00014,881,00014,850,00010,989,00010,877,00073,221,00011,236,00010,683,00010,089,00066,281,00010,577,00011,167,00011,186,00062,010,00012,013,00013,512,00013,952,00057,971,00015,112,00014,037,00012,446,00064,112,00029,024,00027,634,00028,132,00026,807,00025,801,00025,443,00025,323,00024,899,00024,082,00023,165,00024,050,00025,710,00025,123,00025,321,00022,991,00024,132,00021,311,00023,775,00025,248,00039,467,00024,319,00024,144,00023,989,00036,123,00023,291,00023,114,00044,832,00020,730,00020,538,00020,291,16920,293,09620,031,60020,033,69119,964,13520,016,17919,955,97619,931,1879,896,91210,284,98010,288,34410,099,50910,106,85210,103,65210,089,1709,299,56510,089,12910,086,29910,111,06310,085,02310,108,05510,131,90710,056,06710,109,20812,842,94712,691,17512,508,22312,555,37312,240,87812,230,324



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue245,879,000
Cost of Revenue-76,577,000
Gross Profit169,302,000169,302,000
 
Operating Income (+$)
Gross Profit169,302,000
Operating Expense-117,615,000
Operating Income57,144,00051,687,000
 
Operating Expense (+$)
Research Development19,381,000
Selling General Administrative46,466,000
Selling And Marketing Expenses59,465,000
Operating Expense117,615,000125,312,000
 
Net Interest Income (+$)
Interest Income1,058,000
Interest Expense-1,428,000
Other Finance Cost-1,058,000
Net Interest Income-1,428,000
 
Pretax Income (+$)
Operating Income57,144,000
Net Interest Income-1,428,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)60,485,00046,918,000
EBIT - interestExpense = 61,184,000
60,479,000
46,495,000
Interest Expense1,428,000
Earnings Before Interest and Taxes (EBIT)62,612,00061,913,000
Earnings Before Interest and Taxes (EBITDA)75,114,000
 
After tax Income (+$)
Income Before Tax60,485,000
Tax Provision-15,412,000
Net Income From Continuing Ops45,073,00045,073,000
Net Income45,067,000
Net Income Applicable To Common Shares45,073,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses194,192,000
Total Other Income/Expenses Net10,226,0001,428,000
 

Technical Analysis of Dr. Reddy's Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dr. Reddy's Laboratories Limited. The general trend of Dr. Reddy's Laboratories Limited is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dr. Reddy's Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dr. Reddy's Laboratories Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6,023 < 6,306 < 6,506.

The bearish price targets are: 5,990 > 5,970 > 5,521.

Tweet this
Dr. Reddy's Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dr. Reddy's Laboratories Limited. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dr. Reddy's Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dr. Reddy's Laboratories Limited. The current macd is -63.14341869.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dr. Reddy's Laboratories Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dr. Reddy's Laboratories Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dr. Reddy's Laboratories Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dr. Reddy's Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartDr. Reddy's Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dr. Reddy's Laboratories Limited. The current adx is 12.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dr. Reddy's Laboratories Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dr. Reddy's Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dr. Reddy's Laboratories Limited. The current sar is 6,232.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dr. Reddy's Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dr. Reddy's Laboratories Limited. The current rsi is 38.47. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Dr. Reddy's Laboratories Limited Daily Relative Strength Index (RSI) ChartDr. Reddy's Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dr. Reddy's Laboratories Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dr. Reddy's Laboratories Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Dr. Reddy's Laboratories Limited Daily Stochastic Oscillator ChartDr. Reddy's Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dr. Reddy's Laboratories Limited. The current cci is -121.25153283.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Dr. Reddy's Laboratories Limited Daily Commodity Channel Index (CCI) ChartDr. Reddy's Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dr. Reddy's Laboratories Limited. The current cmo is -29.63527702.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dr. Reddy's Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartDr. Reddy's Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dr. Reddy's Laboratories Limited. The current willr is -83.22550288.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Dr. Reddy's Laboratories Limited Daily Williams %R ChartDr. Reddy's Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dr. Reddy's Laboratories Limited.

Dr. Reddy's Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dr. Reddy's Laboratories Limited. The current atr is 121.56.

Dr. Reddy's Laboratories Limited Daily Average True Range (ATR) ChartDr. Reddy's Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dr. Reddy's Laboratories Limited. The current obv is 12,133,654.

Dr. Reddy's Laboratories Limited Daily On-Balance Volume (OBV) ChartDr. Reddy's Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dr. Reddy's Laboratories Limited. The current mfi is 35.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dr. Reddy's Laboratories Limited Daily Money Flow Index (MFI) ChartDr. Reddy's Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dr. Reddy's Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Dr. Reddy's Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dr. Reddy's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.474
Ma 20Greater thanMa 506,105.205
Ma 50Greater thanMa 1006,227.118
Ma 100Greater thanMa 2005,997.993
OpenGreater thanClose6,050.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dr. Reddy's Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Dr. Reddy's Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dr. Reddy's Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dr. Reddy's Laboratories Limited

I send you an email if I find something interesting about Dr. Reddy's Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Dr. Reddy's Laboratories Limited.

Receive notifications about Dr. Reddy's Laboratories Limited in your mailbox!